BLOOM-DM: Behavioral Modification and Lorcaserin for Overweight and Obesity Management in Diabetes Mellitus
Status:
Completed
Trial end date:
2010-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the weight loss effect of lorcaserin during and at the
end of 1 year of treatment in overweight and obese patients with Type II diabetes mellitus
treated with metformin, sulfonylurea (SFU), or either agent in combination with other oral
hypoglycemic agents.